You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

February 1986

Volume 21, Issue S1

Pages 5S–90S

  1. JOURNAL ARTICLE

    1. Top of page
    2. JOURNAL ARTICLE
    3. RANDOMIZED CONTROLLED TRIAL
    4. JOURNAL ARTICLE
    1. You have free access to this content
    2. You have free access to this content
      The alpha 1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. (pages 9S–17S)

      VA Alabaster and MJ Davey

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02848.x

    3. You have free access to this content
      The metabolism and kinetics of doxazosin in man, mouse, rat and dog. (pages 19S–25S)

      B Kaye, NJ Cussans, JK Faulkner, DA Stopher and JL Reid

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02849.x

    4. You have free access to this content
      Clinical pharmacological studies with doxazosin. (pages 27S–31S)

      HL Elliott, PA Meredith, J Vincent and JL Reid

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02850.x

    5. You have free access to this content
      Alpha-adrenergic receptors in human blood vessels. (pages 33S–39S)

      P Van Brummelen, K Jie and PA Van Zwieten

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02851.x

    6. You have free access to this content
      Acute renal effects of doxazosin in man. (pages 41S–43S)

      PW de Leeuw, PN Van Es, R de Bos and WH Birkenhager

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02852.x

    7. You have free access to this content
      Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise. (pages 45S–54S)

      P Lund-Johansen, P Omvik and H Haugland

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02853.x

    8. You have free access to this content
      A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension. (pages 55S–62S)

      MH Frick, P Halttunen, P Himanen, M Huttunen, P Porsti, T Pitkajarvi, L Poyhonen, ML Pyykonen, P Reinikainen, P Salmela and et al

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02854.x

  2. RANDOMIZED CONTROLLED TRIAL

    1. Top of page
    2. JOURNAL ARTICLE
    3. RANDOMIZED CONTROLLED TRIAL
    4. JOURNAL ARTICLE
    1. You have free access to this content
      Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol. (pages 63S–67S)

      MA Baez, DC Garg, NS Jallad and DJ Weidler

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02855.x

  3. JOURNAL ARTICLE

    1. Top of page
    2. JOURNAL ARTICLE
    3. RANDOMIZED CONTROLLED TRIAL
    4. JOURNAL ARTICLE
    1. You have free access to this content
    2. You have free access to this content
      Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins. (pages 77S–81S)

      A Lehtonen, P Himanen, M Saraste, K Niittymaki and J Marniemi

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02857.x

    3. You have free access to this content
      The antihypertensive effects of doxazosin: a clinical overview. (pages 83S–90S)

      DA Cox, JP Leader, JA Milson and W Singleton

      Version of Record online: 26 JUL 2012 | DOI: 10.1111/j.1365-2125.1986.tb02858.x

SEARCH

SEARCH BY CITATION